AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 EyenoviaInfinity PharmaceuticalsOramed PharmaceuticalsCumberland PharmaceuticalsBellerophon Therapeutics
SymbolNASDAQ:EYENNASDAQ:INFINASDAQ:ORMPNASDAQ:CPIXNASDAQ:BLPH
Price Information
Current Price$2.89$0.93$3.14$3.28$14.18
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score2.11.31.31.81.8
Analysis Score3.33.43.53.53.5
Community Score2.32.03.12.23.0
Dividend Score0.00.00.00.00.0
Ownership Score4.01.00.01.02.0
Earnings & Valuation Score0.60.00.02.50.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$6.00$2.17$10.83$9.75$31.67
% Upside from Price Target107.61% upside134.23% upside245.01% upside197.26% upside123.32% upside
Trade Information
Market Cap$57.15 million$53.99 million$76.21 million$49.64 million$85.39 million
Beta2.491.871.650.45-0.71
Average Volume49,198182,412118,37226,601675,485
Sales & Book Value
Annual RevenueN/A$3.05 million$2.70 million$47.53 millionN/A
Price / SalesN/A17.4226.861.05N/A
CashflowN/AN/A$0.79 per share$0.52 per shareN/A
Price / CashN/AN/A3.996.29N/A
Book Value$0.62 per share($0.04) per share$1.12 per share$3.36 per share$0.35 per share
Price / BookN/A-23.132.800.98N/A
Profitability
Net Income$-21,160,000.00$-47,060,000.00$-14,350,000.00$-3,540,000.00$-13,270,000.00
EPS($1.47)($0.83)$0.82$0.23($2.95)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/A21.87N/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-3,308.31%-295.94%-10.28%N/A
Return on Equity (ROE)-171.98%-329.49%-43.25%3.74%-269.64%
Return on Assets (ROA)-141.31%-75.67%-24.11%1.85%-106.98%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.25%N/A0.36%0.69%
Current Ratio5.72%6.27%5.72%2.08%1.34%
Quick Ratio5.72%6.27%5.72%1.69%1.34%
Ownership Information
Institutional Ownership Percentage6.50%48.68%2.62%30.80%37.42%
Insider Ownership Percentage43.10%12.12%20.50%39.72%57.90%
Miscellaneous
EmployeesN/A25N/A8017
Shares Outstanding19.78 million57.43 million23.09 million15.18 million6.13 million
Next Earnings Date8/10/2020 (Estimated)8/4/2020 (Estimated)7/8/2020 (Estimated)8/12/2020 (Estimated)8/13/2020 (Estimated)
OptionableNot OptionableOptionableOptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.